GGrantIndex
← Leaderboards

John L Bixby

University Of Miami School Of Medicine

Google Scholar ↗PubMed ↗ORCID ↗
$10,654,658
Attributed
$16,417,767
Total exposure
10
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1M · FY2005–25
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$16,417,767 · 10

By mechanism

R01$11,731,986 · 6
UH3$1,959,367 · 1
T32$1,846,571 · 1
UG3$650,295 · 1
U01$229,548 · 1

Top collaborators

Most similar at University Of Miami School Of Medicine

Same institution · by research overlap

Others in their field

Top investigators on “Axon”

Research focus

AxonNeuronsSpinal Cord InjuryNatural RegenerationGrowthInjuryIn VivoCentral Nervous System InjuryAxon RegenerationPharmaceutical PreparationsAxon GrowthIn VitroInjuredLeadPhenotypeNeuritesSpinal CordMolecularScreeningCellsBrainRattusBaseInvestigation

Grant awards (54)

Developing a kinase inhibitor drug to treat spinal cord injury$500,994
UH3 · FY2025 · NS
Developing a kinase inhibitor drug to treat spinal cord injury$77,520
UH3 · FY2025 · NS
Developing a kinase inhibitor drug to treat spinal cord injury$619,619
UH3 · FY2024 · NS
Developing a kinase inhibitor drug to treat spinal cord injury$78,486
UH3 · FY2024 · NS
Developing a kinase inhibitor drug to treat spinal cord injury$606,139
UH3 · FY2023 · NS
Developing a kinase inhibitor drug to treat spinal cord injury$76,609
UH3 · FY2023 · NS
Developing a kinase inhibitor drug to treat spinal cord injury$650,295
UG3 · FY2022 · NS
Targeting Multiple Kinases to Treat Experimental Spinal Cord Injury$465,464
R01 · FY2021 · NS
Targeting Multiple Kinases to Treat Experimental Spinal Cord Injury.$16,781
R01 · FY2021 · NS
Targeting Multiple Kinases to Treat Experimental Spinal Cord Injury$465,464
R01 · FY2020 · NS
Targeting Multiple Kinases to Treat Experimental Spinal Cord Injury$465,464
R01 · FY2019 · NS
Novel Gene Targets for CNS Axonal Regeneration$470,519
R01 · FY2018 · HD
Targeting Multiple Kinases to Treat Experimental Spinal Cord Injury$465,464
R01 · FY2018 · NS
Targeting Multiple Kinases to Treat Experimental Spinal Cord Injury$474,406
R01 · FY2017 · NS
Novel Gene Targets for CNS Axonal Regeneration$470,519
R01 · FY2017 · HD
Novel Gene Targets for CNS Axonal Regeneration$465,813
R01 · FY2016 · HD
Regenbase: A Searchable Database to Organize Regeneration Knowledge via Ontologie$570,144
R01 · FY2015 · NS
Novel Gene Targets for CNS Axonal Regeneration$458,758
R01 · FY2015 · HD
Regenbase: A Searchable Database to Organize Regeneration Knowledge via Ontologie$564,445
R01 · FY2014 · NS
Novel Gene Targets for CNS Axonal Regeneration$470,519
R01 · FY2014 · HD
Regenbase: A Searchable Database to Organize Regeneration Knowledge via Ontologie$550,188
R01 · FY2013 · NS
Novel Compounds That Overcome Glial Inhibition of Axonal Regeneration$316,514
R01 · FY2013 · NS · contact PI
Regenbase: A Searchable Database to Organize Regeneration Knowledge via Ontologie$603,798
R01 · FY2012 · NS
Novel Compounds That Overcome Glial Inhibition of Axonal Regeneration$327,994
R01 · FY2012 · NS · contact PI
Triazine-based compounds to promote regeneration in optic neuropathies$32,792
U01 · FY2012 · NS · contact PI
Novel Compounds That Overcome Glial Inhibition of Axonal Regeneration$327,994
R01 · FY2011 · NS · contact PI
Triazine-based compounds to promote regeneration in optic neuropathies$196,756
U01 · FY2011 · NS · contact PI
Novel Compounds That Overcome Glial Inhibition of Axonal Regeneration$331,341
R01 · FY2010 · NS · contact PI
Predoctoral Training Program in the Neurosciences$208,985
T32 · FY2010 · NS · contact PI
Novel Compounds That Overcome Glial Inhibition of Axonal Regeneration$68,850
R01 · FY2010 · NS · contact PI
Novel Compounds That Overcome Glial Inhibition of Axonal Regeneration$330,746
R01 · FY2009 · NS · contact PI
Predoctoral Training Program in the Neurosciences$215,897
T32 · FY2009 · NS · contact PI
Novel Compounds That Overcome Glial Inhibition of Axonal Regeneration$44,628
R01 · FY2009 · NS · contact PI
RPTPs in the Growth of Vertebrate Axons$330,334
R01 · FY2008 · NS · contact PI
Predoctoral Training Program in the Neurosciences$214,796
T32 · FY2008 · NS · contact PI
Predoctoral Training Program in the Neurosciences$864
T32 · FY2008 · NS · contact PI
RPTPs in the Growth of Vertebrate Axons$330,334
R01 · FY2007 · NS · contact PI
Predoctoral Training Program in the Neurosciences$214,796
T32 · FY2007 · NS · contact PI
RPTPs in the Growth of Vertebrate Axons$338,107
R01 · FY2006 · NS · contact PI
Predoctoral Training Program in the Neurosciences$182,471
T32 · FY2006 · NS · contact PI
RPTPs in the Growth of Vertebrate Axons$84,840
R01 · FY2006 · NS · contact PI
RPTPs in the Growth of Vertebrate Axons$346,005
R01 · FY2005 · NS
PREDOCTORAL TRAINING PROGRAM IN THE NEUROSCIENCES$168,357
T32 · FY2005 · NS
RPTPs in the Growth of Vertebrate Axons$343,861
R01 · FY2004 · NS
PREDOCTORAL TRAINING PROGRAM IN THE NEUROSCIENCES$168,357
T32 · FY2004 · NS
PREDOCTORAL TRAINING PROGRAM IN THE NEUROSCIENCES$164,884
T32 · FY2003 · NS
RECEPTOR TYROSINE PHOSPHATASES IN THE GROWTH OF AXONS$280,566
R01 · FY2002 · NS
PREDOCTORAL TRAINING PROGRAM IN THE NEUROSCIENCES$157,056
T32 · FY2002 · NS
PREDOCTORAL TRAINING PROGRAM IN THE NEUROSCIENCES$1,070
T32 · FY2002 · NS
RECEPTOR TYROSINE PHOSPHATASES IN THE GROWTH OF AXONS$272,410
R01 · FY2001 · NS
PRESYNAPTIC ACTIONS OF AGRIN$210,661
R01 · FY2001 · NS
PREDOCTORAL TRAINING PROGRAM IN THE NEUROSCIENCES$149,038
T32 · FY2001 · NS
RECEPTOR TYROSINE PHOSPHATASES IN THE GROWTH OF AXONS$264,478
R01 · FY2000 · NS
PRESYNAPTIC ACTIONS OF AGRIN$204,577
R01 · FY2000 · NS